The North America Pharmaceutical Excipients Market was worth USD 1.91 billion in 2018 and estimated to be growing at a CAGR of 5.42%, to reach USD 2.46 billion by 2023. An excipient is a natural or synthetic constituent formulated alongside the active ingredient of a medication, included for the purpose of inducing and catalysing a wide range of physical and chemical properties.
The North America market for Pharmaceutical Excipients is broadly categorized by Product, by Functionality and by Formulation Type. Based on Product it is further categorized into Organic Chemicals (Oleochemicals, Carbohydrates, Petrochemicals, Proteins, Other Organic Chemicals) and Inorganic Chemicals (Calcium Phosphates, Metal Oxides, Halites, Calcium Carbonates, Calcium Sulphates, Other Inorganic Chemicals). Based on Functionality the Pharmaceutical Excipients are divided into subcategories like Fillers & Diluents, Binders, Suspension & Viscosity Agents, Coatings, Disintegrants, Flavouring Agents, Lubricants & Glidants, Colorants, Preservatives, Others). On basis of type of formulations, it is segmented into Oral Formulations, Topical Formulations, Parenteral Formulations and Advanced Delivery Systems. The fillers & diluents segment accounted for the largest share of the pharmaceutical excipients market while the lubricant & Glidants segment will witness the highest growth.
On the basis of geography, the North America market is analysed in a country level as USA and Canada. North America occupy the majority of the share in the global market, accounting for almost 1/3 of the revenue. USA dominates the North America market but the growth is stunted here as compared to international counterparts due to saturation of the market and stringent regulatory policies.
Increasing incidences of chronic diseases owing to sedentary life style, hefty investments by the pharmaceutical companies in development of medicines, implementing new novelties like nanotechnology are the major driving forces of the market. However, decreasing the side-effects of drugs and developing environmental friendly manufacturing processes are the major challenges faced by the pharmaceutical industry.
However, proper expansion strategies, launching new product pipeline would be a lucrative opportunity for the companies operating in this industries but the growth of the market is hindered to a certain level by the fact that investments in R&D by major companies are not up to the required level and increasing regulatory requirements are making it increasingly hard to get new manufacturing facilities approved which are definite threats to overcome.
Emerging players in this market are giving a stiff competition to the top 10 players who occupy almost 70% of the total market. It can be attributed to the rapid growth of the market and opportunities it possesses in developing countries. Some of the key players operating in the field are Ashland Inc., AkzoNobel, Archer Daniels Midland Company, Associated British Foods PLC, BASF SE, Colorcon, Inc., Croda International PLC, Evonik Industries AG, FMC Corporation, Innophos Holdings Inc., J.M. Huber Corporation, Merck Millipore, Roquette Group, The DOW Chemical Company and Lubrizol Corporation.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Product
5.1.1 Organic Chemicals
5.1.1.1 Oleochemicals
5.1.1.2 Carbohydrates
5.1.1.3 Petrochemicals
5.1.1.4 Proteins
5.1.1.5 Other Organic Chemicals
5.1.2 Inorganic Chemicals
5.2.1.1 Calcium Phosphates
5.2.1.2 Metal Oxides
5.2.1.3 Halites
5.2.1.4 Calcium Carbonates
5.2.1.5 Calcium Sulfates
5.2.1.6 Other Inorganic Chemicals
5.2 By Functionality
5.2.1 Fillers & Diluents
5.2.2 Binders
5.2.3 Suspension & Viscosity Agents
5.2.4 Coatings
5.2.5 Disintegrants
5.2.6 Flavoring Agents
5.2.7 Lubricants & Glidants
5.2.8 Colorants
5.2.9 Preservatives
5.2.10 Other Functionalities
5.3 By Formulation Type
5.3.1 Oral Formulations
5.3.1.1 Tablets
5.3.1.2 Capsules
5.3.1.3 Liquid Formulations
5.3.2 Topical Formulations
5.3.3 Parenteral Formulations
5.3.4 Advanced Delivery Systems
6. Geographical Analysis
6.1 Introduction
6.2 United States
6.3 Canada
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Ashland Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 AkzoNobel
8.3 Archer Daniels Midland Company
8.4 Associated British Foods PLC
8.5 BASF SE,
8.6 Colorcon, Inc.
8.7 Croda International PLC
8.8 Evonik Industries AG
8.9 FMC Corporation
8.1 Innophos Holdings Inc.,
8.11 J.M. Huber Corporation
8.12 Merck Millipore
8.13 Roquette Group
8.14 The DOW Chemical Company
8.15 The Lubrizol Corporation
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
